Protagonist Therapeutics CEO Dinesh V. Patel disposes of common shares worth USD 18.25 million
PTGX•CEO reports option exercises and same-day share sales
Protagonist Therapeutics President, CEO, director Dinesh V. Patel filed a Form 4 reporting option exercises with same-day share sales on Sept. 8-10.
- Sold 125,000 shares for about $18.25 million, at weighted average prices of $145.87, $146.18, and $144.10.
- Exercised options for 125,000 shares at $21.58 per share.
- Directly owned 522,968 shares following the transactions.
